Irbesartan is a non-peptide angiotensin II-competitive antagonist indicated for hypertension and diabetic nephropathy in hypertensive patients with type 2 diabetes, elevated serum creatinine, and proteinuria [74]. This evidence concerns the gene AGT and type 2 diabetes mellitus.